Hepatitis B Virus Studies
Hepatitis B Virus Studies is a research topic within Epidemiology. Science Explorer counts 58k research works in it since 1950. 15.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, clinical management, antiviral therapy, and global burden of hepatitis B virus (HBV) infection. It covers topics such as chronic hepatitis B, hepatocellular carcinoma, viral hepatitis, antiviral therapy, vaccine prevention, and the immune response to HBV infection.
- Hepatitis B Virus
- Chronic Hepatitis B
- Viral Hepatitis
- HBV Infection
- Hepatocellular Carcinoma
- Antiviral Therapy
- Global Burden
- Vaccine Prevention
- Liver Disease
- Immune Response
- Research works
- 58k fractional, since 1950
- In the world top 10%
- 9.2k per year above
- Top-10% rate
- 15.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -5% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Hepatitis B Virus Studies research?
By volume, China and the United States publish the most (1.4k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 1.4k works
- 2 United States 1.1k works
- 3 India 436 works
- 4 Japan 223 works
- 5 Türkiye 216 works
- 6 United Kingdom 212 works
- 7 France 198 works
- 8 Germany 192 works
- 9 Pakistan 188 works
- 10 Brazil 185 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Hepatitis B Virus Studies research?
By volume in 2022–2025, Peking University publishes the most Hepatitis B Virus Studies research, followed by University of North Carolina at Chapel Hill and Sun Yat-sen University.
By volume, 2022–2025
- 1 Peking UniversityChina 33 works
- 2 University of North Carolina at Chapel HillUnited States 31 works
- 3 Sun Yat-sen UniversityChina 28 works
- 4 Capital Medical UniversityChina 27 works
- 5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 23 works
- 6 InsermFrance 21 works
- 7 Chongqing Medical UniversityChina 20 works
- 8 Fujian Medical UniversityChina 19 works
- 9 Southern Medical UniversityChina 19 works
- 10 Chinese University of Hong KongHong Kong 18 works
Who are the leading researchers in Hepatitis B Virus Studies?
The most-cited researchers publishing on Hepatitis B Virus Studies include Reza Malekzadeh, Louisa Degenhardt and Winfried März.
- 1 Reza Malekzadeh Iran 6.7k citations
- 2 Louisa Degenhardt Australia 5.7k citations
- 3 Winfried März Germany 5.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Hepatitis B Virus Studies research done?
The largest centres of Hepatitis B Virus Studies research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and London (United Kingdom).
Where is the best place to study Hepatitis B Virus Studies?
Among universities, judged by research, Chinese University of Hong Kong, University of Gondar and University of Hong Kong score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese University of Hong KongHong Kong | 60.5 | 31.9% | 3.7× | 18 | +1.0% |
| 2 | University of GondarEthiopia | 59.1 | 17.9% | 9.5× | 10 | +309.7% |
| 3 | University of Hong KongHong Kong | 55.9 | 30.4% | 2.8× | 17 | -5.9% |
| 4 | Capital Medical UniversityChina | 55.1 | 19.1% | 6.8× | 27 | +5.2% |
| 5 | Medizinische Hochschule HannoverGermany | 53.0 | 18.4% | 9.8× | 15 | -37.9% |
| 6 | Peking UniversityChina | 52.7 | 22.6% | 3.0× | 33 | +4.3% |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 51.9 | 28.4% | 3.4× | 23 | -9.1% |
| 8 | Southern Medical UniversityChina | 51.3 | 18.4% | 7.6× | 19 | -1.1% |
| 9 | Fujian Medical UniversityChina | 51.0 | 17.5% | 7.9× | 19 | +2.4% |
| 10 | Chongqing Medical UniversityChina | 49.5 | 14.7% | 8.5× | 20 | -10.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Hepatitis B Virus Studies research growing?
Output in 2018–2022 was 5% lower than in 2013–2017, peaking in 2015. The fastest-growing topics are Hepatitis B Virus Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.